TFO
RMD icon

Tarbox Family Office’s ResMed RMD Stock Holding History

Tarbox Family Office’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29
Closed -$7K – 794
2022
Q1 		$7K Sell
29
-30
-51% -$7.26K ﹤0.01% 444
2021
Q4 		$15K Buy
59
+5
+9% +$1.3K ﹤0.01% 397
2021
Q3 		$14K Hold
54
– – ﹤0.01% 441
2021
Q2 		$13K Hold
54
– – ﹤0.01% 446
2021
Q1 		$10K Sell
54
-7
-11% -$1.4K ﹤0.01% 422
2020
Q4 		$13K Buy
61
+7
+13% +$1.4K ﹤0.01% 369
2020
Q3 		$9K Buy
54
+26
+93% +$4.8K ﹤0.01% 402
2020
Q2 		$5K Buy
28
+25
+833% +$4.09K ﹤0.01% 489
2020
Q1 		$0 Buy
+3
New +$478 ﹤0.01% 1279
2018
Q4 		– Sell
-188
Closed -$22K – 637
2018
Q3 		$22K Hold
188
– – 0.01% 237
2018
Q2 		$19K Sell
188
-41
-18% -$4.15K 0.01% 238
2018
Q1 		$23K Buy
+229
New +$21.6K 0.01% 226

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Tarbox Family Office's RMD Position: Q2 2022 in Review

Tarbox Family Office sold out of ResMed (RMD) in Q2 2022, closing a stake of 29 shares — an estimated $7K sold.

Tarbox Family Office first reported a position in RMD in Q1 2018 and held it in 12 quarters. The position peaked at $23K in Q1 2018. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Tarbox Family Office reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 29 ResMed shares in Q2 2022, an estimated $7K.
  • Tarbox Family Office first reported a position in ResMed in Q1 2018 and held it in 12 quarters.
  • Tarbox Family Office's ResMed position peaked at $23K in Q1 2018.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.